Curcumin Inhibits Gastric Inflammation Induced by Helicobacter Pylori Infection in a Mouse Model

Nutrients

Volumn 7, Issue 1, 2015, Pages 306-320

  Santos, António M ^a,b   Lopes, Teresa ^b   Oleastro, Mónica ^c   Gato, Inês Vale ^c   Floch, Pauline ^d   Benejat, Lucie ^d   Chaves, Paula ^e   Pereira, Teresa ^e   Seixas, Elsa ^b   Machado, Jorge ^c   Guerreiro, António S ^a,b  

^a Serviço de Medicina 4—Hospital de Santa Marta/Centro Hospitalar de Lisboa Central ^*  (Portugal)

^b NOVA MEDICAL SCHOOL   (Portugal)

^c NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

^d UNIVERSITÉ DE BORDEAUX   (France)

^e INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

Author keywords

Curcumin; H. pylori; Mouse model; Nutritional approach; Secondary prevention

Indexed keywords

CHEMOKINE; CURCUMIN; CYTOKINE; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR; ANTIINFLAMMATORY AGENT; MYD88 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; GASTRITIS; GENE EXPRESSION; GENETIC CODE; HELICOBACTER INFECTION; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; UREA BREATH TEST; ANIMAL; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; GASTRIC MUCOSA; GENETICS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; METABOLISM; MICROBIOLOGY; UPREGULATION;

HELICOBACTER PYLORI; MUS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CURCUMIN; DISEASE MODELS, ANIMAL; GASTRIC MUCOSA; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; MALE; MICE; MICE, INBRED C57BL; MYELOID DIFFERENTIATION FACTOR 88; REAL-TIME POLYMERASE CHAIN REACTION; TOLL-LIKE RECEPTORS; UP-REGULATION;

EID: 84920545584     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu7010306     Document Type: Article

References (48)

1. Suarez, G.; Reyes, V.E.; Beswick, E.J. Immune response to H. pylori. World. J. Gastroenterol. 2006, 12, 5593–5598.
2. IARC Working Group. Schistosomes, liver flukes and Helicobacter pylori. In Proceedings of The International Agency for Research on Cancer Working Group on the Evaluation of Carcinogenic Risks to Humans, Lyon, France, 7–14 June 1994; IARC Monographs on the Evaluation of Carcinogenic Risks to Humans;World Health Organization: Geneva, Switzerland, 1994; Volume 61, pp. 1–241.
3. Correa, P. Human gastric carcinogenesis: A multistep and multifactorial process—First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992, 52, 6735–6740.
4. Lee, A.; O’Rourke, J.; de Ungria, M.C.; Robertson, B.; Daskalopoulos, G.; Dixon, M.F. A standardized mouse model of Helicobacter pylori infection: Introducing the Sydney strain. Gastroenterology 1997, 112, 1386–1397.
5. Verbeke, H.; Geboes, K.; van Damme, J.; Struyf, S. The role of CXC chemokines in the transition of chronic inflammation to esophageal and gastric cancer. Biochim. Biophys. Acta 2012, 1825, 117–129.
6. Backert, S.; Naumann, M. What a disorder: Proinflammatory signaling pathways induced by Helicobacter pylori. Trends. Microbiol. 2010, 18, 479–486.
7. Chuchart, K.; Sukanya, L.; Don, C.; Kriangkrai, C.; Jiraprapa, W. Investigation of the anti-inflammatory effect of Curcuma longa in Helicobacter pylori-infected patients. Int. Immunopharmacol. 2010, 10, 815–818.
8. Rad, R.; Brenner, L.; Krug, A.; Voland, P.; Mages, J.; Lang, R.; Schwendy, S.; Reindl, W.; Dossumbekova, A.; Ballhorn, W. Toll-like receptor-dependent activation of antigen-presenting cells affects adaptive immunity to Helicobacter pylori. Gastroenterology 2007, 133, 150–163.
9. Bengmark, S.; Mesa, M.D.; Gil, A. Plant-derived health: The effects of turmeric and curcuminoids. Nutr. Hosp. 2009, 24, 273–281.
10. Balachandran, P.; Govindarajan, R. Cancer—An ayurvedic perspective. Pharmacol. Res. 2005, 51, 19–30.
11. Surth, Y.J. Anti-tumor promoting potential of selected spice ingredients with antioxidative and anti-inflammatory activities: A short review. Food Chem. Toxicol. 2002, 40, 1091–1097.
12. Kewitz, S.; Volkmer, I.; Staege, M. Curcuma contra cancer? Curcumin and Hodgkin’s Lymphoma. Cancer Growth Metastasis 2013, 6, 35–52.
13. Premkumar, K.; Kavitha, S.; Santhiya, S.T.; Ramesh, A.R.; Suwanteerangkul, J. Interactive effects of saffron with garlic and curcumin against cyclophosphamide induced genotoxicity in mice. Asia Pac. J. Clin. Nutr. 2004, 13, 292–294.
14. Anand, P.; Kunnumakkara, A.B.; Newman, R.A.; Aggarwal, B.B. Bioavailability of curcumin: Problems and promises. Mol. Pharm. 2007, 4, 807–818.
15. 13C-urea breath test in experimental model of Helicobacter pylori infection in mice. Helicobacter 2011, 16, 320–326.
16. Oleastro, M.; Ménard, A.; Santos, A.; Lamouliatte, H.; Monteiro, L.; Barthélémy, P.; Mégraud, F. Real-time PCR assay for rapid and accurate detection of point mutations conferring resistance to clarithromycin in Helicobacter pylori. J. Clin. Microbiol. 2003, 41, 397–402.
17. Ferrand, J.; Lehours, P.; Schmid-Alliana, A.; Mégraud, F.; Varon, C. Helicobacter pylori infection of gastrointestinal epithelial cells in vitro induces mesenchymal stem cell migration through an NF-κB-dependent pathway. PLoS One 2011, 6, doi:10.1371/0029007.
18. Jones, N.L.; Day, A.S.; Jennings, H.; Patrick, T.; Shannon, P.T.; Galindo-Mata, E.; Sherman, P.M. Enhanced disease severity in Helicobacter pylori-infected mice deficient in Fas signaling. Infect. Immun. 2002, 70, 2591–2597.
19. Sintara, K.; Duangporn, T.-N.; Suthiluk, P.; Naruemon, K.; Tanittha, C. Curcumin suppresses gastric NF-kappaB activation and macromolecular leakage in Helicobacter pylori-infected rats. World. J. Gastroenterol. 2010, 16, 4039–4046.
20. Di Mario, F.; Cavallaro, L.G.; Nouvenne, A; Stefani, N.; Cavestro, G.M.; Iori, V.; Maino, M.; Comparato, G.; Fanigliulo, L.; Morana, E. A curcumin-based 1-week triple therapy for eradication of Helicobacter pylori infection: Something to learn from failure? Helicobacter 2007, 12, 238–243.
21. Kundu, P.; de, R.; Pal, I.; Mukhopadhyay, A.K.; Saha, D.R.; Swarnakar, S. Curcumin alleviates matrix metalloproteinase-3 and -9 activities during eradication of Helicobacter pylori infection in cultured cells and mice. PLoS One 2011, 6, doi:10.1371/0016306.
22. Goel, A.; Kunnumakkara, A.; Aggarwal, B. Curcumin as “Curecumin”: From kitchen to clinic. Biochem. Pharmacol. 2008, 75, 787–809.
23. Bodger, K.; Crabtree, J. Helicobacter pylori and gastric inflammation. Br. Med. Bull. 1998, 54, 139–150.
24. Wu, Y.; Tsai, H.; Lin, W.; Hsu, P.; Shun, C.; Wu, M.; Hsu, P. Upregulation of CCL20 and recruitment of CCR6+ gastric infiltrating lymphocytes in Helicobacter pylori gastritis. Infect. Immun. 2007, 75, 4357–4363.
25. Yoshida, A.; Isomoto, H.; Hisatsune, J.; Nakayama, M.; Nakashima, Y.; Matsushima, K.; Mizuta, Y.; Hayashi, T.; Yamaoka, Y.; Azuma, T. Enhanced expression of CCL20 in human Helicobacter pylori-associated gastritis. Clin. Immunol. 2009, 130, 290–297.
26. Eck, M.; Schmausser, B.; Scheller, K.; Toksoy, A.; Kraus, M.; Menzel, T.; Müller-Hermelink, H.; Gillitzer, R. CXC chemokines Gro/IL-8 and IP-10/MIG in Helicobacter pylori gastritis. Clin. Exp. Immunol. 2000, 122, 192–199.
27. Crabtree, J.; Shallcross, R.; Heatley, R.; Wyatt, J. Mucosal tumor necrosis factor-alpha and interleukin-6 in patients with Helicobacter pylori-associated gastritis. Gut 1991, 32, 1473–1477.
28. Noach, L.; Bosma, N.; Jansen, J.; Hoek, F.; Deventer, S.; Tytgat, G. Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand. J. Gastroenterol. 1994, 29, 425–429.
29. Redecke, V.; Hacker, H.; Datta, S.K.; Fermin, A.; Pitha, P.M.; Broide, D.H. Cutting edge: Activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J. Immunol. 2004, 172, 2739–2743.
30. Dillon, S.; Agrawal, A.; Van, D.T.; Landreth, G.; McCauley, L.; Koh, A. A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells. J. Immunol. 2004, 172, 4733–4743.
31. Pulendran, B. Variegation of the immune response with dendritic cells and pathogen recognition receptors. J. Immunol. 2005, 174, 2457–2465.
32. Rad, R.; Ballhorn, W.; Voland, P.; Eisenächer, K.; Mages, J.; Rad, L.; Ferstl, R.; Lang, R.; Wagner, H.; Schmid, R. Extracellular and intracellular pattern recognition receptors cooperate in the recognition of Helicobacter pylori. Gastroenterology 2009, 136, 2247–2257.
33. Akira, S.; Uematsu, S.; Takeuchi, O. Pathogen recognition and innate immunity. Cell 2006, 124, 783–801.
34. Kabir, S. The role of interleukin-17 in the Helicobacter pylori induced infection and immunity. Helicobacter 2011, 16, 1–8.
35. Zhuang, Y.; Shi, Y.; Liu, X.; Zhang, J.; Liu, T.; Fan, X.; Luo, J.; Wu, C.; Yu, S.; Chen, L. Helicobacter pylori-infected macrophages induce Th17 cell differentiation. Immunobiology 2011, 216, 200–207.
36. Shi, Y.; Liu, X.; Zhuang, Y.; Zhang, J.; Liu, T.; Yin, Z.; Wu, C.; Mao, X.; Jia, K.; Wang, F. Helicobacter pylori-induced Th17 responses modulate Th1 cell responses, benefit bacterial growth, and contribute to pathology in mice. J. Immunol. 2010, 184, 5121–5129.
37. Eaton, K.A.; Mefford, M.; Thevenot, T. The role of T cell subsets and cytokines in the pathogenesis of Helicobacter pylori gastritis in mice. J. Immunol. 2001, 166, 7456–7461.
38. Karttunen, R.; Karttunen, T.; Ekre, H.P.; MacDonald, T.T. Interferon gamma and interleukin 4 secreting cells in the gastric antrum in Helicobacter pylori positive and negative gastritis. Gut 1995, 36, 341–345.
39. Bamford, K.B.; Fan, X.; Crowe, S.E.; Leary, J.F.; Gourley, W.K.; Luthra, G.K.; Brooks, E.G.; Graham, D.Y.; Reyes, V.E.; Ernst, P.B. Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology 1998, 114, 482–492.
40. Smythies, L.E.; Waites, K.B.; Lindsey, J.R.; Harris, P.R.; Ghiara, P.; Smith, P.D. Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-gamma, gene-deficient mice. J. Immunol. 2000, 165, 1022–1029.
41. Brandt, S.; Kwok, T.; Hartig, R.; König, W.; Backert, S. NF-κB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein. Proc. Natl. Acad. Sci. USA 2005, 102, 9300–9305.
42. Ghosh, S.; Karin, M. Missing pieces in the NF-κB puzzle. Cell 2002, 109, 81–96.
43. Li, Q.; Verma, I.M. NF-κB regulation in the immune system. Nat. Rev. Immunol. 2002, 2, 725–734.
44. Singh, S.; Aggarwal, B.B. Activation of transcription factor NF-κB is suppressed by curcumin (diferuloylmethane). J. Biol. Chem. 1995, 270, 24995–25000.
45. Kumar, A.; Dhawan, S.; Hardegen, N.J.; Aggarwal, B.B. Curcumin (diferuloylmethane) inhibition of tumor necrosis factor (TNF)-mediated adhesion of monocytes to endothelial cells by suppression of cell surface expression of adhesion molecules and of nuclear factor-kappaB activation. Biochem. Pharmacol. 1998, 55, 775–783.
46. Jobin, C.; Bradham, C.A.; Russo, M.P.; Juma, B.; Narula, A.S.; Brenner, D.A.; Sartor, R.B. Curcumin blocks cytokine-mediated NF-κB activation and proinflammatory gene expression by inhibiting inhibitory factor I-κB kinase activity. J. Immunol. 1999, 163, 3474–3483.
47. Foryst-Ludwig, A.; Neumann, M.; Schneider-Brachert, W.; Naumann, M. Curcumin blocks NF-κB and the motogenic response in Helicobacter pylori-infected epithelial cells. Biochem. Biophys. Res. Commun. 2004, 316, 1065–1072.
48. Lambert, J.D.; Hong, J.; Yang, G.; Liao, J.; Yang, C.S. Inhibition of carcinogenesis by polyphenols: Evidence from laboratory investigations. Am. J. Clin. Nutr. 2005, 81, 284–291.